Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian individualization via sampling-based methods

J Wakefield1

  • 1Department of Epidemiology and Public Health, Imperial College School of Medicine at St. Mary's, London, United Kingdom.

Journal of Pharmacokinetics and Biopharmaceutics
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in <i>Escherichia coli</i> O157:H7 infections - ERRATUM.

Epidemiology and infection·2019
Same author

Responding to Mycobacterium chimaera heater-cooler unit contamination: international and national intersectoral collaboration coordinated in the state of Queensland, Australia.

The Journal of hospital infection·2018
Same author

Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.

Epidemiology and infection·2018
Same author

Hyak mortality monitoring system: innovative sampling and estimation methods - proof of concept by simulation.

Global health, epidemiology and genomics·2018
Same author

Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.

Epidemiology and infection·2015
Same author

Detecting signals in pharmacogenomic genome-wide association studies.

The pharmacogenomics journal·2014
Same journal

Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Pharmacokinetics of methotrexate in solid tumors.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Journal of pharmacokinetics and biopharmaceutics·2010
Same journal

Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Journal of pharmacokinetics and biopharmaceutics·2010
See all related articles

This study presents a Bayesian approach to optimize drug dosage regimens using sparse patient data. It enables personalized medicine by minimizing expected loss for improved therapeutic outcomes.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Bayesian Statistics
  • Computational Biology

Background:

  • Optimizing drug dosage regimens is crucial for effective patient treatment.
  • Sparse on-line concentration measurements present challenges in real-time dosage adjustments.
  • Existing methods may not fully account for pharmacokinetic parameter uncertainty.

Purpose of the Study:

  • To develop a Bayesian decision theory framework for adjusting patient dosage regimens.
  • To provide a method for estimating pharmacokinetic parameters from sparse data.
  • To minimize the expected loss associated with dosage regimens.

Main Methods:

  • Utilizing Bayesian decision theory with specified prior distributions and loss functions.
  • Employing a Monte Carlo method to sample posterior distributions of pharmacokinetic parameters.

Related Experiment Videos

  • Minimizing the estimated expected loss with respect to the dosage regimen.
  • Developing methods to incorporate population analysis and parameter uncertainty.

    • Main Results:

    • A practical method for obtaining posterior samples of pharmacokinetic parameters was developed.
    • The approach allows for Monte Carlo estimation and minimization of expected loss.
    • Analytic solutions were identified for special cases.
    • A method for accounting for uncertainty in population parameters was described.

    Conclusions:

    • The proposed Bayesian framework offers a robust method for personalized dosage regimen optimization.
    • The approach effectively utilizes sparse on-line measurements for adaptive therapy.
    • Simulation studies demonstrate the practical applicability and efficacy of the developed methods.